Related Experiment Video
Updated: May 28, 2026

10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Radiotherapy-Induced Neuronal Dysfunction in Patients with Brain Tumors: Dose-Volume Effects, Imaging Biomarkers and
Carla-Bianca Vulturar1,2, Nicolae Verga3, Olivian Savencu3
1Department of Radiation Oncology, Clinic Medeuropa, 410191 Oradea, Romania.
Diagnostics (Basel, Switzerland)
|May 27, 2026
Summary
Radiation therapy for brain tumors can harm healthy brain tissue, affecting neuronal function and cognition. Integrating radiation dose metrics and advanced imaging may help predict and mitigate these effects.
Area of Science:
- Neuro-oncology
- Radiation Oncology
- Neurology
Background:
- Brain tumors are a significant cause of neurological disability and death.
- Radiotherapy is crucial for brain tumor treatment but can induce adverse effects in healthy brain tissue.
- Understanding radiation-induced neuronal dysfunction is vital for improving patient outcomes.
Purpose of the Study:
- To synthesize evidence on radiation-induced neuronal dysfunction.
- To integrate dose-volume parameters, neuroimaging biomarkers, and clinical manifestations.
- To provide a structured overview for risk stratification and neuroprotection.
Main Methods:
- Structured literature review of PubMed, Scopus, and Web of Science.
- Inclusion of studies on dose-volume effects, neuroimaging, and clinical outcomes post-cranial radiotherapy.
- Synthesis of data linking radiation parameters to neurological effects.
Main Results:
- Dose-volume histogram (DVH) parameters (mean brain dose, V10-V30, hippocampal dose) correlate with cognitive decline.
- Conventional MRI shows structural changes (white matter injury, radionecrosis).
- Advanced MRI (DTI, fMRI) detects microstructural damage and network disruption, correlating with clinical deficits.
Conclusions:
- Radiation-induced neuronal dysfunction is complex, involving more than just tissue injury.
- Combining dose-volume data with advanced imaging biomarkers can enhance risk assessment.
- This integration may facilitate the development of neuroprotective strategies for radiotherapy patients.
Keywords:
brain tumorscognitive impairmentdose–volume effectsneuroimagingneuronal dysfunctionradiation-induced brain injuryradiotherapy
